Cytochrome P450 inhibitor, Deferasirox, Purity ≥98%

Cat. No.: X24-08-YM374

Cytochrome P450 inhibitor, Deferasirox, Purity ≥98%

Synonym: 201530-41-8; ICL-670; ICL-670A; CGP-72670; 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid

  • MDL: MFCD09751362
  • CAS Number: 201530-41-8
  • Compound CID: 214348
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Deferasirox, soluble in DMSO and ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450.
Molecular Weight
373.36
Molecular Formula
C21H15N3O4
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 64 mg/mL (171.42 mM); Water: insoluble; Ethanol: 2 mg/mL; In vivo: 5% DMSO + 40% PEG 300 + 5% Tween 80 + 50% H2O, 3.5 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Deferasirox is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of chronic iron overload due to conditions such as thalassemia or sideroblastic anemia, often resulting from repeated blood transfusions.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.